Correction: Management of Relapsed and Refractory Multiple Myeloma: Novel Agents, Antibodies, Immunotherapies and Beyond
Leukemia - United Kingdom
doi 10.1038/s41375-019-0410-3
Full Text
Open PDFAbstract
Available in full text
Date
March 6, 2019
Authors
Publisher
Springer Science and Business Media LLC